Gryllus bimaculatus (Gb) was orally administered at doses of 0, 0.04, 0.2, 1 and 5 g/kg bw/day for 13 consecutive weeks. There were no observed clinical signs or deaths related to treatment in all the groups tested. Therefore, the approximate lethal oral dose of G. bimaculatus was considered to be higher than 5 g/ kg in rats. Throughout the administration period, no significant changes in diet consumption, ophthalmologic findings, organ weight, clinical pathology (hematology, clinical chemistry, coagulation, and urinalysis) or gross pathology were detected. Minor changes were found in hematological parameters for the 5 g/ kg Gb-treated group (triglyceride reduction of 35.8%), but all changes were within normal physiological ranges. Microscopic examination did not identify any treatment-related histopathologic changes in the organs of Gb-treated rats in the high dose group. From these results, one can conclude that the no-observed adverse effect level (NOAEL) of G. bimaculatus is higher than 5 g/kg bw/day in rats.
INTRODUCTION
Cricket (Gryllus bimaculatus) water extract has been used in oriental medicine as a crude drug for treating fever and hypertension and the cricket is presently reared as food (Ahn et al., 2005) . The main components of Gryllus bimaculatus are protein, fat including essential fatty acids-oleic acid, linoleic acid and γ-linoleic acid, ash, and moisture (Ahn et al., 2000) . Recently, the extracts from Gryllus bimaculatus, were found to cause a significant decrease in blood ethanol concentrations by enhancing liver mitochondrial alcohol metabolizing enzymes (Ahn et al., 2004) . In other countries, like grasshopper, the cricket (Gryllus bimaculatus) is eaten after roasting, but, it was not consumed as a food in Korea. Safety evaluation data on these products is limited.
The acute toxicity of G. bimaculatus in Sprague-Dawley rats was tested and it was practically non-toxic with an oral LD 50 value of > 5 g/kg . A genotoxic evaluation of the biocomponents of cricket (Gryllus bimaculatus) was assessed using three mutagenicity tests: the Ames test, the chromosome aberration test in Chinese ham-Food consumption. Daily food consumption was determined by subtracting leftover feed from provided feed. Food consumption was measured daily for the 1 st week and weekly thereafter.
Urine sampling. During the final week of testing (week 13), rats were transferred to metabolic cages for 24 hr and urine was collected to determine specific gravity, pH, leukocyte content, nitrite, protein, glucose, ketone, urobilinogen, bilirubin and hemoglobin levels using commercial kits (Roche Diagonisctics GmbH, Mannheim, Germany).
Blood sampling and plasma assay. After 13 weeks of treatment, blood (~3 ml) was collected from the posterior vena cava under light CO 2 inhalation and used for serum chemistry measurements. The parameters examined included total protein, albumin, total bilirubin, glucose, glutamic pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT), γ-glutamyl transferase (GGT), alkaline phosphatase (ALP), lactic dehydrogenase (LDH), total cholesterol, blood urea nitrogen (BUN), creatinine, triglyceride, uric acid, sodium, potassium and chloride. All were evaluated using an autoanalyzer (Hitachi 7060 automatic clinical analyzer, Tokyo).
Organ weights. Absolute and relative (organ-to-body weight ratios) weights were determined after sacrifice at 13 weeks; tissues included brain, pituitary gland, adrenal glands, liver, spleen, kidneys, heart, thymus, lung, stomach, thyroid gland and testes (or ovary).
Pathology and histopathology. The organs and tissues in the cranial, thoracic, and abdominal cavities of euthanized rats, were examined grossly for ophthalmic observation. Each organ was excised and fixed in phosphate-buffered formalin. After paraffin embedding, the excised organs and tissues were prepared for microscopic examination by sectioning and staining with hematoxylin and eosin.
Statistical analysis. Mean and standard deviation of all parameters were determined for each of the 5 groups. A Student's t-test was used to establish the significant differences between the control and treatment groups. p < 0.05 was considered statistically significant.
RESULTS

Clinical signs and food consumption.
No deaths or adverse clinical signs were observed due to the ingestion of G. bimaculatus at doses of 0.04, 0.2, 1.0 and 5.0 g/kg/day (Table 1) . Food consumption was similar for all study groups (Fig. 1) .
Body weight changes. There were no toxicologically significant differences in mean body weight between any of the treatment groups (Fig. 2) . During the 13-week administration period, the body weights of the male and female SD rats in the 3 treatment groups were comparable across the control and treated groups. The mean weekly body weights versus time are presented in Fig. 2 . No statistically significant differences were observed between the 5.0 g/kg G. bimaculatus-treated group and the control group.
Urinalysis. No significant differences were observed between treatment and control group (Table 2) .
Hematology and blood chemistry. Some dose-dependent changes were observed between the treated and control groups with respect to the hematological parameters at the end of the experiment. An increase in partial thromboplastin time count was observed in the male rats in the treated groups; (control, 118.3 ± 30.8 sec; 0.04 g/kg, 91.5 ± 44.1 sec; 0.20 g/kg, 96.7 ± 13.3 sec; 1.0 g/kg, 122.7 ± 40.4 sec; 5.0 g/kg, 132.6 ± 28.6 sec) and the same trends were seen in females (Table 3 and Table 4 ) but without significant differences. Hematocrit, MCV, MCHC and Factor I (indicators of RBS function and status) were significantly different between some of the treated groups versus the control group. Minor changes were found in hematological parameters (eosinophils, neutrophils, lymphocytes and basophils) for some Gb-treated (one side) male or female rat groups. But, effects of Gb were not considered adverse because all changes in hematological data were within the normal physiological range (Table 3 and Table 4 ).
Serum biochemistry.
In the sera of the Gb-treated groups, trigyceride levels were significantly lower than in the control after 13 weeks with dose-dependent changes in both males (control, 82.7 ± 18.9 mg/dl; 1.0 g/kg, 60.3 ± 11.1 mg/dl), and females (control, 93.7 ± 59.4 mg/dl; 1.0 g/ kg, 54.4 ± 7.1 mg/dl). Serum glucose levels were lower vs control in the males (control, 403.0 ± 69.6 mg/dl; 1.0 g/kg, 293.5 ± 81.0 mg/dl), and females (controls, 309.1 ± 90.2 mg/dl; 1.0 g/kg, 147.8 ± 53.2 mg/dl). A significant increase in HDL cholesterol was observed in the 0.04 and 1.0 g/kg groups for both the males and females (male: control, 12.0 ± 2.2 mg/dl; 0.04 g/kg, 15.5 ± 3.9 mg/dl; 1.0 g/kg, 16.0 ± 2.2 mg/ Fig. 1 . Food consumption of male and female SD rats, treated orally with G. bimaculatus powder over a 13-week period *Significantly different from the untreated controls (P < 0.05).
Fig. 2.
Body weight increases of male and female SD rats, treated orally with G. bimaculatus powder over a 13-week period. *Significantly different from the untreated controls (P < 0.05).
dl; female: control, 25.5 ± 8.3 mg/dl; 0.04 g/kg, 29.1 ± 3.7 mg/ dl; 1.0 g/kg, 31.0 ± 3.8 mg/dl).
Alkaline phosphatase (ALP) levels of the treated groups were reduced in a dose-dependent manner in males (control, 133.5 ± 16.4 mg/dl; 1.0 g/kg, 109.9 ± 17.5 mg/dl), and females (controls, 169.0 ± 121.8 mg/dl; 1.0 g/kg, 93.8 ± 14.0 mg/dl). Also, uric acid levels of the treated groups were reduced in a dose-dependent manner in males (control, 8.7 ± 1.6 mg/dl; 1.0 g/kg, 6.8 ± 1.0 mg/dl), and females (control, 6.6 ± 2.0 mg/dl; 1.0 g/kg, 5.4 ± 0.8 mg/dl).
Calcium ion levels of the treated groups were reduced in a dose-dependent manner in males (control, 13.0 ± 0.3 nmol/l; 1.0 g/kg, 12.2 ± 0.5 nmol/l) and females (control, 13.0 ± 0.7 nmol/l; 1.0 g/kg, 11.6 ± 0.9 nmol/l), whereas inorganic phosphorus levels increased (male: control, 18.9 ± 3.3 nmol/l; 5.0 g/kg, 14.9 ± 2.6 nmol/l, female: control, 17.7 ± 5.7 mg/dl; 1.0 g/kg, 15.0 ± 2.0 mg/dl) ( Tables 4 and 5 ). However, Gb was considered non-toxic because the all changes in serum biochemical data were within normal physiological range (Tables 5 and 6 ).
Pathology and organ weight. No significant treatmentrelated pathologies were observed. Any minor changes were few and dose-independent. At the end of the administration period, there were no treatment-related changes in absolute (Table 7) or relative organ weights (Table 8 ). There were some histopathological findings observed, however the histopathological alterations at the end of the adminis- tration period were not related to treatment as finding were dose independent. There were no detectable pathological findings for either sex. Furthermore, there were no adverse findings that presented in the 13-week repeated toxicity test (Table 9, Table 10 ).
DISCUSSION
G. bimaculatus belongs to Gryllidae, Ortoptera and is used as a natural food for humans and reptiles in Southeast Asia and Africa (Cui et al., 2002) . Owing to the develop- ments. Accordingly, last year, an industrial entomology rearing law was announced. Therefore, more safety data will be needed for insect food approval in the future. Recently, it was reported that the primary pharmacological activities of G. bimaculatus include selective hepatoprotective activities Kwon et al., 2004) and alcohol metabolizing enzyme induction in rats (Ahn et al., 2004) .
The safety of Gb has been evaluated systematically in a series of acute and sub-acute toxicological tests showing only slight acute (single dose) toxicity with an oral LD 50 value of > 5 g/kg . Another safety study on the extract of cricket was reported. G. bimaculatus at doses of 0 (vehicle), 0.025, 0.05, 0.1 and 0.2 mg/kg for 2 weeks were examined. On the other hand, a previous report showed that a dose of 0.2 mg/kg of a water/methanol cricket extract had protective effects on acute hepatic damage in ICR-mice induced by the administration of CCl 4 . The same extract dosage (0.2 mg/kg) was used to evaluate the alcohol-induced toxicity in Gb as an alcohol metabolizing enhancer via liver mitochondrial alcohol dehydrogenase and acetaldehyde dehydrogenase (Ahn et al., 2004) . Therefore, the repeated upper oral dose in subchronic toxicity study would need to be more than 0.2 mg/kg, such as 0.5 g/kg or 1 g/kg for calculating of NOAEL. In this acute oral toxicity study of Gb in SD rats, Gb did not induce any remarkable toxic responses and the LD 50 was previously reported as > 5 g/kg . After a dose range finding (DRF), the safety of Gb at doses of 0, 0.04, 0.2, 1 and 5 g/kg was examined over 13 consecutive weeks. Treatment at 5.0 g/kg/day with Gb resulted in a decrease in serum triglycerides and glucose in a dose-dependent manner in both sexes but all changes were within normal physiological range. There were no clinical signs or deaths related to treatment in any of the groups tested. Therefore, the approximate lethal oral dose of G. bimaculatus was considered to be > 5 g/kg/day in rats. Throughout the administration period, no significant changes in diet consumption, ophthalmologic findings, organ weight, clinical pathology (hematology, clinical chemistry, coagulation, and urinalysis) and gross pathology were detected. Minor changes were noted in hematological and biochemical serum parameters for the 0.04. 0.2, 1, 5 g/kg/day Gbtreated groups, but all changes were within the normal phys- 
